Shared Gene Expression Alterations in Schizophrenia and Bipolar Disorder
Schizophrenia and bipolar disorder together affect approximately 2.5% of the world population, and their etiologies are thought to involve multiple genetic variants and environmental influences. The analysis of gene expression patterns in brain may provide a characteristic signature for each disorde...
Saved in:
| Published in | Biological psychiatry (1969) Vol. 64; no. 2; pp. 89 - 97 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
New York, NY
Elsevier Inc
15.07.2008
Elsevier Science |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Schizophrenia and bipolar disorder together affect approximately 2.5% of the world population, and their etiologies are thought to involve multiple genetic variants and environmental influences. The analysis of gene expression patterns in brain may provide a characteristic signature for each disorder.
RNA samples from the dorsolateral prefrontal cortex (Brodmann area 46) consisting of individuals with schizophrenia (SZ), bipolar disorder (BPD), and control subjects were tested on the Codelink Human 20K Bioarray platform. Selected transcripts were validated by quantitative real-time polymerase chain reaction (PCR). The strong effects of age, gender, and pH in the analysis of differential gene expression were controlled by analysis of covariance (ANCOVA). Criteria for differential gene expression were 1) a gene was significantly dysregulated in both BPD and SZ compared with control subjects and 2) significant in ANCOVA analysis with samples that have a pH above the median of the sample.
A list of 78 candidate genes passed these two criteria in BPD and SZ and was overrepresented for functional categories of nervous system development, immune system development and response, and cell death. Five dysregulated genes were confirmed with quantitative Q-PCR in both BPD and SZ. Three genes were highly enriched in brain expression (AGXT2L1, SLC1A2, and TU3A). The distribution of AGXT2L1 expression in control subjects versus BPD and SZ was highly significant (Fisher's Exact Test,
p < 10
−06).
These results suggest a partially shared molecular profile for both disorders and offer a window into discovery of common pathophysiology that might lead to core treatments. |
|---|---|
| AbstractList | Schizophrenia and bipolar disorder together affect approximately 2.5% of the world population, and their etiologies are thought to involve multiple genetic variants and environmental influences. The analysis of gene expression patterns in brain may provide a characteristic signature for each disorder.
RNA samples from the dorsolateral prefrontal cortex (Brodmann area 46) consisting of individuals with schizophrenia (SZ), bipolar disorder (BPD), and control subjects were tested on the Codelink Human 20K Bioarray platform. Selected transcripts were validated by quantitative real-time polymerase chain reaction (PCR). The strong effects of age, gender, and pH in the analysis of differential gene expression were controlled by analysis of covariance (ANCOVA). Criteria for differential gene expression were 1) a gene was significantly dysregulated in both BPD and SZ compared with control subjects and 2) significant in ANCOVA analysis with samples that have a pH above the median of the sample.
A list of 78 candidate genes passed these two criteria in BPD and SZ and was overrepresented for functional categories of nervous system development, immune system development and response, and cell death. Five dysregulated genes were confirmed with quantitative Q-PCR in both BPD and SZ. Three genes were highly enriched in brain expression (AGXT2L1, SLC1A2, and TU3A). The distribution of AGXT2L1 expression in control subjects versus BPD and SZ was highly significant (Fisher's Exact Test, p < 10(-06)).
These results suggest a partially shared molecular profile for both disorders and offer a window into discovery of common pathophysiology that might lead to core treatments. Schizophrenia and bipolar disorder together affect approximately 2.5% of the world population, and their etiologies are thought to involve multiple genetic variants and environmental influences. The analysis of gene expression patterns in brain may provide a characteristic signature for each disorder. RNA samples from the dorsolateral prefrontal cortex (Brodmann area 46) consisting of individuals with schizophrenia (SZ), bipolar disorder (BPD), and control subjects were tested on the Codelink Human 20K Bioarray platform. Selected transcripts were validated by quantitative real-time polymerase chain reaction (PCR). The strong effects of age, gender, and pH in the analysis of differential gene expression were controlled by analysis of covariance (ANCOVA). Criteria for differential gene expression were 1) a gene was significantly dysregulated in both BPD and SZ compared with control subjects and 2) significant in ANCOVA analysis with samples that have a pH above the median of the sample. A list of 78 candidate genes passed these two criteria in BPD and SZ and was overrepresented for functional categories of nervous system development, immune system development and response, and cell death. Five dysregulated genes were confirmed with quantitative Q-PCR in both BPD and SZ. Three genes were highly enriched in brain expression (AGXT2L1, SLC1A2, and TU3A). The distribution of AGXT2L1 expression in control subjects versus BPD and SZ was highly significant (Fisher's Exact Test, p < 10 −06). These results suggest a partially shared molecular profile for both disorders and offer a window into discovery of common pathophysiology that might lead to core treatments. Schizophrenia and bipolar disorder together affect approximately 2.5% of the world population, and their etiologies are thought to involve multiple genetic variants and environmental influences. The analysis of gene expression patterns in brain may provide a characteristic signature for each disorder.BACKGROUNDSchizophrenia and bipolar disorder together affect approximately 2.5% of the world population, and their etiologies are thought to involve multiple genetic variants and environmental influences. The analysis of gene expression patterns in brain may provide a characteristic signature for each disorder.RNA samples from the dorsolateral prefrontal cortex (Brodmann area 46) consisting of individuals with schizophrenia (SZ), bipolar disorder (BPD), and control subjects were tested on the Codelink Human 20K Bioarray platform. Selected transcripts were validated by quantitative real-time polymerase chain reaction (PCR). The strong effects of age, gender, and pH in the analysis of differential gene expression were controlled by analysis of covariance (ANCOVA). Criteria for differential gene expression were 1) a gene was significantly dysregulated in both BPD and SZ compared with control subjects and 2) significant in ANCOVA analysis with samples that have a pH above the median of the sample.METHODSRNA samples from the dorsolateral prefrontal cortex (Brodmann area 46) consisting of individuals with schizophrenia (SZ), bipolar disorder (BPD), and control subjects were tested on the Codelink Human 20K Bioarray platform. Selected transcripts were validated by quantitative real-time polymerase chain reaction (PCR). The strong effects of age, gender, and pH in the analysis of differential gene expression were controlled by analysis of covariance (ANCOVA). Criteria for differential gene expression were 1) a gene was significantly dysregulated in both BPD and SZ compared with control subjects and 2) significant in ANCOVA analysis with samples that have a pH above the median of the sample.A list of 78 candidate genes passed these two criteria in BPD and SZ and was overrepresented for functional categories of nervous system development, immune system development and response, and cell death. Five dysregulated genes were confirmed with quantitative Q-PCR in both BPD and SZ. Three genes were highly enriched in brain expression (AGXT2L1, SLC1A2, and TU3A). The distribution of AGXT2L1 expression in control subjects versus BPD and SZ was highly significant (Fisher's Exact Test, p < 10(-06)).RESULTSA list of 78 candidate genes passed these two criteria in BPD and SZ and was overrepresented for functional categories of nervous system development, immune system development and response, and cell death. Five dysregulated genes were confirmed with quantitative Q-PCR in both BPD and SZ. Three genes were highly enriched in brain expression (AGXT2L1, SLC1A2, and TU3A). The distribution of AGXT2L1 expression in control subjects versus BPD and SZ was highly significant (Fisher's Exact Test, p < 10(-06)).These results suggest a partially shared molecular profile for both disorders and offer a window into discovery of common pathophysiology that might lead to core treatments.CONCLUSIONSThese results suggest a partially shared molecular profile for both disorders and offer a window into discovery of common pathophysiology that might lead to core treatments. BackgroundSchizophrenia and bipolar disorder together affect approximately 2.5% of the world population, and their etiologies are thought to involve multiple genetic variants and environmental influences. The analysis of gene expression patterns in brain may provide a characteristic signature for each disorder. MethodsRNA samples from the dorsolateral prefrontal cortex (Brodmann area 46) consisting of individuals with schizophrenia (SZ), bipolar disorder (BPD), and control subjects were tested on the Codelink Human 20K Bioarray platform. Selected transcripts were validated by quantitative real-time polymerase chain reaction (PCR). The strong effects of age, gender, and pH in the analysis of differential gene expression were controlled by analysis of covariance (ANCOVA). Criteria for differential gene expression were 1) a gene was significantly dysregulated in both BPD and SZ compared with control subjects and 2) significant in ANCOVA analysis with samples that have a pH above the median of the sample. ResultsA list of 78 candidate genes passed these two criteria in BPD and SZ and was overrepresented for functional categories of nervous system development, immune system development and response, and cell death. Five dysregulated genes were confirmed with quantitative Q-PCR in both BPD and SZ. Three genes were highly enriched in brain expression (AGXT2L1, SLC1A2, and TU3A). The distribution of AGXT2L1 expression in control subjects versus BPD and SZ was highly significant (Fisher's Exact Test, p < 10 −06). ConclusionsThese results suggest a partially shared molecular profile for both disorders and offer a window into discovery of common pathophysiology that might lead to core treatments. |
| Author | Shao, Ling Vawter, Marquis P. |
| Author_xml | – sequence: 1 givenname: Ling surname: Shao fullname: Shao, Ling – sequence: 2 givenname: Marquis P. surname: Vawter fullname: Vawter, Marquis P. email: mvawter@uci.edu |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20487621$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/18191109$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNUk1v1DAQtVAR3Rb-QpUL3BJsJ44TCVW0pbRIlTgsnC3HmZBZsnawsxXLr8dhtwV6oJxsj9978_HmiBxYZ4GQE0YzRln5epU16MawNX3GKZUZYxll9AlZsErmKS8oPyALSmmZ5pznh-QohFV8Ss7ZM3LIKlYzRusFuV722kObXIGF5PL76CEEdDY5GybweorXkKBNlqbHH27sPVjUibZtco6jG7RP3mFwvgX_nDzt9BDgxf48Jp_fX366uE5vPl59uDi7SY0o2ZSKRnKhteZNLdoSaiHyrioLpoVpadeCFKbi2ggOTUGFbGQua05lC63pRF11-TE53emOm2Ydo2Anrwc1elxrv1VOo_r7x2KvvrhbldO6iiVEgVd7Ae--bSBMao3BwDBoC24TVFnzCC1EBJ78mek-xd3wIuDlHqCD0UPntTUY7nGcFpUs-Zyx3OGMdyF46H5LUTW7qVbqzk01u6kYU9HNSHzzgGhw-mVK7AyHx-lvd3SIftwieBUMgjXQogczqdbh4xKnDyTMgBZjt19hC2HlNt5GtxVTgSuqlvPGzQtHJY0jKvJ_C_xPBT8BjGHqyw |
| CODEN | BIPCBF |
| CitedBy_id | crossref_primary_10_1016_j_jad_2023_04_074 crossref_primary_10_1038_mp_2014_53 crossref_primary_10_1093_ijnp_pyx115 crossref_primary_10_1007_s00429_018_1737_7 crossref_primary_10_1074_jbc_M111_323485 crossref_primary_10_1038_tp_2012_112 crossref_primary_10_1016_j_jpsychires_2012_11_007 crossref_primary_10_1093_schbul_sbab039 crossref_primary_10_1038_mp_2012_37 crossref_primary_10_1111_jne_12339 crossref_primary_10_1038_tp_2015_210 crossref_primary_10_1016_j_jpsychires_2021_08_011 crossref_primary_10_1016_j_neuroimage_2010_06_036 crossref_primary_10_1016_j_jbc_2021_100830 crossref_primary_10_1016_j_ebiom_2017_01_010 crossref_primary_10_1016_j_schres_2011_12_015 crossref_primary_10_3109_01677063_2011_597908 crossref_primary_10_1080_15622975_2019_1583371 crossref_primary_10_1002_humu_21042 crossref_primary_10_1038_s41398_022_02302_4 crossref_primary_10_1002_glia_20798 crossref_primary_10_1007_s00109_021_02070_6 crossref_primary_10_1007_s15202_019_2300_y crossref_primary_10_1038_s41598_019_54355_z crossref_primary_10_1016_j_schres_2019_09_007 crossref_primary_10_1093_hmg_ddw181 crossref_primary_10_1371_journal_pgen_1005487 crossref_primary_10_1111_acps_13418 crossref_primary_10_3389_fncel_2023_1097512 crossref_primary_10_1038_s41386_022_01338_w crossref_primary_10_1080_19440049_2018_1562232 crossref_primary_10_1093_bfgp_elr036 crossref_primary_10_1016_j_biopsych_2017_03_018 crossref_primary_10_1038_tp_2013_94 crossref_primary_10_1159_000438788 crossref_primary_10_3390_ijms252313107 crossref_primary_10_1016_j_jad_2012_05_037 crossref_primary_10_1186_1471_244X_9_57 crossref_primary_10_1007_s12035_019_01815_2 crossref_primary_10_1016_j_psyneuen_2014_06_009 crossref_primary_10_1038_npp_2009_225 crossref_primary_10_1371_journal_pone_0049183 crossref_primary_10_1016_j_pmip_2022_100093 crossref_primary_10_2174_0929867331666230713143322 crossref_primary_10_1534_g3_119_400723 crossref_primary_10_1002_ajmg_b_32248 crossref_primary_10_1186_s12864_019_5974_9 crossref_primary_10_1016_j_jad_2024_01_238 crossref_primary_10_1371_journal_pone_0038211 crossref_primary_10_1371_journal_pone_0119021 crossref_primary_10_1016_j_bbrc_2021_04_042 crossref_primary_10_1016_j_nbd_2011_08_025 crossref_primary_10_1111_febs_13122 crossref_primary_10_1111_j_1399_5618_2010_00805_x crossref_primary_10_1186_s12868_014_0130_6 crossref_primary_10_1038_srep29395 crossref_primary_10_1016_j_psyneuen_2018_03_004 crossref_primary_10_1038_s41398_020_01084_x crossref_primary_10_1002_jcp_30993 crossref_primary_10_1016_j_biopsych_2013_04_024 crossref_primary_10_1016_j_neulet_2021_135943 crossref_primary_10_1016_j_neubiorev_2011_09_001 crossref_primary_10_1038_ejhg_2014_261 crossref_primary_10_1016_j_nbd_2011_01_025 crossref_primary_10_1016_j_neulet_2009_07_092 crossref_primary_10_1080_09540260902962180 crossref_primary_10_3389_fgene_2021_718976 crossref_primary_10_1159_000501885 crossref_primary_10_1093_ijnp_pyaa021 crossref_primary_10_1021_pr800876z crossref_primary_10_1038_mp_2016_90 crossref_primary_10_1016_j_neuroscience_2009_04_038 crossref_primary_10_1038_tp_2016_173 crossref_primary_10_1038_npp_2017_167 crossref_primary_10_7717_peerj_15834 crossref_primary_10_1038_s41598_019_49718_5 crossref_primary_10_1186_s12920_015_0098_9 crossref_primary_10_1093_schbul_sbae102 crossref_primary_10_1016_j_euroneuro_2012_01_010 crossref_primary_10_3892_br_2014_243 crossref_primary_10_1016_j_jpsychires_2010_04_011 crossref_primary_10_1007_s11064_020_03212_x crossref_primary_10_1002_brb3_23 crossref_primary_10_31887_DCNS_2014_16_4_egershon crossref_primary_10_1016_j_schres_2013_11_004 crossref_primary_10_1002_wps_20730 crossref_primary_10_1016_j_schres_2012_11_004 crossref_primary_10_2174_0929867326666190325095223 crossref_primary_10_1097_YPG_0b013e32835bd5f1 crossref_primary_10_1176_appi_focus_130111 crossref_primary_10_3389_fgene_2022_816660 crossref_primary_10_1002_iub_1178 crossref_primary_10_1016_j_neubiorev_2017_04_003 crossref_primary_10_1016_j_neuron_2022_10_031 crossref_primary_10_1016_j_pnpbp_2009_05_003 crossref_primary_10_1186_1471_244X_13_213 crossref_primary_10_1038_s41398_020_00958_4 crossref_primary_10_3390_toxics10090518 crossref_primary_10_1038_tp_2016_229 crossref_primary_10_1007_s12035_016_0041_x crossref_primary_10_1016_j_nbd_2011_03_001 crossref_primary_10_3389_fpsyg_2021_672786 crossref_primary_10_1016_j_schres_2009_03_008 crossref_primary_10_1111_j_1601_183X_2010_00578_x crossref_primary_10_1111_sji_12620 crossref_primary_10_1107_S2053230X20002988 crossref_primary_10_1016_j_neubiorev_2009_01_004 crossref_primary_10_1248_bpb_b24_00251 crossref_primary_10_1016_j_psychres_2015_06_013 crossref_primary_10_1038_tp_2014_8 crossref_primary_10_3390_ijms19123993 crossref_primary_10_1016_j_schres_2014_10_055 crossref_primary_10_1002_hup_1032 crossref_primary_10_1016_j_jad_2017_11_068 crossref_primary_10_1093_schbul_sbab093 crossref_primary_10_1038_s41398_021_01297_8 crossref_primary_10_1016_j_schres_2018_09_010 crossref_primary_10_1038_mp_2016_195 crossref_primary_10_1186_s12864_016_2713_3 crossref_primary_10_1186_1471_2202_14_105 crossref_primary_10_1016_j_schres_2019_07_036 crossref_primary_10_5498_wjp_v12_i2_268 crossref_primary_10_1038_npp_2008_172 crossref_primary_10_1016_j_jpsychires_2013_05_021 crossref_primary_10_1038_nprot_2010_78 crossref_primary_10_1093_nar_gkt145 crossref_primary_10_1002_dneu_22044 crossref_primary_10_1038_mp_2012_146 crossref_primary_10_1002_ajmg_b_32284 crossref_primary_10_1177_0004867419857808 crossref_primary_10_5498_wjp_v12_i2_264 crossref_primary_10_1016_j_freeradbiomed_2023_02_017 crossref_primary_10_1038_mp_2016_241 crossref_primary_10_1016_j_neubiorev_2015_12_001 |
| Cites_doi | 10.1016/S0140-6736(03)12379-3 10.1016/j.biopsych.2006.12.021 10.1093/schbul/sbj033 10.1016/j.neulet.2006.01.021 10.1093/hmg/ddh065 10.1186/1471-244X-4-21 10.1016/j.biopsych.2005.03.031 10.1016/j.biopsych.2006.02.013 10.1016/j.biopsych.2004.10.034 10.1073/pnas.0507901102 10.1016/j.biopsych.2003.10.013 10.1016/j.brainres.2006.11.047 10.1097/01.yco.0000218603.25346.8f 10.1086/342734 10.2174/1567202043362388 10.1016/j.neuroscience.2005.10.003 10.1016/j.jneumeth.2004.04.002 10.1385/NMM:5:1:011 10.1176/appi.ajp.160.8.1392 10.1038/sj.mp.4001532 10.1126/science.1083328 10.1016/j.jneumeth.2007.06.001 10.1097/FPC.0b013e328011b5b2 10.1073/pnas.0400782101 10.1038/sj.npp.1300337 10.1186/1471-2105-6-269 10.1192/bjp.190.4.361 10.1038/sj.npp.1300976 10.1016/j.jneumeth.2007.03.022 10.1176/appi.ajp.158.9.1393 10.1038/sj.mp.4001437 10.1093/hmg/ddi022 10.1093/schbul/sbm053 10.1046/j.1471-4159.1999.720879.x 10.1016/S0893-133X(01)00370-0 10.1016/j.biopsych.2006.03.082 10.1034/j.1399-5618.2002.01203.x 10.1186/1471-2105-4-37 10.1136/jmg.2005.030718 10.2174/1566524033479672 10.1038/sj.mp.4001830 10.1192/bjp.186.5.364 10.1016/S0028-3908(03)00198-9 10.1111/j.2517-6161.1995.tb02031.x 10.1016/j.brainres.2006.05.043 10.1001/archpsyc.61.3.300 |
| ContentType | Journal Article |
| Copyright | 2008 Society of Biological Psychiatry Society of Biological Psychiatry 2008 INIST-CNRS 2008 Society of Biological Psychiatry 2008 |
| Copyright_xml | – notice: 2008 Society of Biological Psychiatry – notice: Society of Biological Psychiatry – notice: 2008 INIST-CNRS – notice: 2008 Society of Biological Psychiatry 2008 |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 5PM |
| DOI | 10.1016/j.biopsych.2007.11.010 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Biology |
| EISSN | 1873-2402 |
| EndPage | 97 |
| ExternalDocumentID | PMC3098561 18191109 20487621 10_1016_j_biopsych_2007_11_010 S0006322307011043 1_s2_0_S0006322307011043 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIMH NIH HHS grantid: R01 MH085801 – fundername: NIMH NIH HHS grantid: R21 MH074307 – fundername: NIMH NIH HHS grantid: R21MH074307 |
| GroupedDBID | --- --K --M -DZ .1- .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 23N 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 6J9 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXLA AAXUO AAYWO ABBQC ABCQJ ABCQX ABDPE ABFNM ABFRF ABIVO ABJNI ABLJU ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFO ACIEU ACIUM ACNCT ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGWIK AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEG HMK HMO HMQ HVGLF HZ~ H~9 IHE J1W KOM L7B M29 M2V M39 M41 MO0 MOBAO N9A O-L O9- OAUVE OH0 OU- OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SNS SPCBC SSH SSN SSZ T5K UAP UNMZH UPT UV1 WH7 WUQ XJT XOL Z5R ZCA ZGI ZKB ZXP ~G- AFCTW AGRNS RIG AACTN AADPK AAIAV ABLVK ABYKQ AFKWA AJBFU AJOXV AMFUW EFLBG G8K LCYCR ZA5 AAYXX CITATION 08R ABPIF ABPTK IQODW CGR CUY CVF ECM EIF NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c561t-5b725aaa2b95d6e9553f8641a5cd0fde75c82ac52eb4057b7379207dedcf598f3 |
| IEDL.DBID | AIKHN |
| ISSN | 0006-3223 1873-2402 |
| IngestDate | Thu Aug 21 18:21:15 EDT 2025 Fri Jul 11 12:21:42 EDT 2025 Fri May 30 11:01:08 EDT 2025 Sun Oct 22 16:04:17 EDT 2023 Tue Jul 01 03:21:12 EDT 2025 Thu Apr 24 22:57:07 EDT 2025 Fri Feb 23 02:26:56 EST 2024 Wed Jun 18 06:48:28 EDT 2025 Tue Aug 26 16:31:10 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | quantitative PCR SLC1A2 TU3A apoptosis BUB1B schizophrenia dorsolateral prefrontal cortex FGF2 PVR RERG LGALS3 bipolar disorder FTH1 ERBB2 neurogenesis SOX9 antipsychotic medication EMX2 AGXT2L1 NFATC1 microarray SMO IL2RA MAFG SMCY TXNIP Psychotropic Neuroleptic Pharmacotherapy Schizophrenia BUB1 B Bipolar disorder Basic fibroblast growth factor Genetic determinism Neurogenesis Psychosis Dorsolateral prefrontal cortex Genetics Antipsychotic Mood disorder Gene expression Polymerase chain reaction Treatment Molecular biology Apoptosis |
| Language | English |
| License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c561t-5b725aaa2b95d6e9553f8641a5cd0fde75c82ac52eb4057b7379207dedcf598f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 18191109 |
| PQID | 69230945 |
| PQPubID | 23479 |
| PageCount | 9 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3098561 proquest_miscellaneous_69230945 pubmed_primary_18191109 pascalfrancis_primary_20487621 crossref_primary_10_1016_j_biopsych_2007_11_010 crossref_citationtrail_10_1016_j_biopsych_2007_11_010 elsevier_sciencedirect_doi_10_1016_j_biopsych_2007_11_010 elsevier_clinicalkeyesjournals_1_s2_0_S0006322307011043 elsevier_clinicalkey_doi_10_1016_j_biopsych_2007_11_010 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2008-07-15 |
| PublicationDateYYYYMMDD | 2008-07-15 |
| PublicationDate_xml | – month: 07 year: 2008 text: 2008-07-15 day: 15 |
| PublicationDecade | 2000 |
| PublicationPlace | New York, NY |
| PublicationPlace_xml | – name: New York, NY – name: United States |
| PublicationTitle | Biological psychiatry (1969) |
| PublicationTitleAlternate | Biol Psychiatry |
| PublicationYear | 2008 |
| Publisher | Elsevier Inc Elsevier Science |
| Publisher_xml | – name: Elsevier Inc – name: Elsevier Science |
| References | Jarskog (bib24) 2006; 19 Altar, Jurata, Charles, Lemire, Liu, Bukhman (bib15) 2005; 58 Lee, Braynen, Keshav, Pavlidis (bib12) 2005; 6 Tomita, Vawter, Walsh, Evans, Choudary, Li (bib8) 2004; 55 McCullumsmith, Meador-Woodruff (bib28) 2005; 26 Craddock, Owen (bib2) 2005; 186 Smith, Haroutunian, Davis, Meador-Woodruff (bib29) 2001; 158 D'Sa, Duman (bib39) 2002; 4 Chen, Zeng, Yuan, Huang, Jiang, Zhao (bib25) 1999; 72 Thompson, Lauderdale, Webster, Chong, McClintock, Saunders (bib41) 2007; 1139 Vawter, Tomita, Meng, Bolstad, Li, Evans (bib9) 2006; 11 Konradi, Eaton, MacDonald, Walsh, Benes, Heckers (bib48) 2004; 61 Iwamoto, Bundo, Kato (bib7) 2005; 14 McQuillin, Rizig, Gurling (bib26) 2007; 17 Duman, Monteggia (bib34) 2006; 59 Prabakaran, Swatton, Ryan, Huffaker, Huang, Griffin (bib47) 2004; 9 Dias, Banerjee, Duman, Vaidya (bib38) 2003; 45 Law (bib43) 2003; 160 Li JZ, Meng F, Tsavaler L, Evans SJ, Choudary PV, Tomita H, et al. (2007): Sample matching by inferred agonal stress in gene expression analyses of the brain. 8:336. Galfalvy, Erraji-Benchekroun, Smyrniotopoulos, Pavlidis, Ellis, Mann (bib14) 2003; 4 Craddock, O'Donovan, Owen (bib4) 2007; 190 Deng, Shibata, Ninomiya, Tashiro, Iwata, Ozaki (bib33) 2004; 4 Atz, Walsh, Cartagena, Li, Evans, Choudary (bib18) 2007; 163 Erraji-Benchekroun, Underwood, Arango, Galfalvy, Pavlidis, Smyrniotopoulos (bib13) 2005; 57 Dranovsky, Hen (bib21) 2006; 59 Sun, Wang, Tseng, Young (bib46) 2006; 31 Iwamoto, Kakiuchi, Bundo, Ikeda, Kato (bib6) 2004; 9 Santarelli, Saxe, Gross, Surget, Battaglia, Dulawa (bib22) 2003; 301 Choudary, Molnar, Evans, Tomita, Li, Vawter (bib27) 2005; 102 Duman (bib37) 2004; 5 Craddock, O'Donovan, Owen (bib3) 2006; 32 Harwood (bib23) 2003; 3 Craddock, O'Donovan, Owen (bib1) 2005; 42 Harrison, Owen (bib45) 2003; 361 Berger UV, Hediger MA (2006): Distribution of the glutamate transporters GLT-1 (SLC1A2) and GLAST (SLC1A3) in peripheral organs. 211:595–606. Lauriat, Dracheva, Chin, Schmeidler, McInnes, Haroutunian (bib31) 2006; 137 Li, Vawter, Walsh, Tomita, Evans, Choudary (bib16) 2004; 13 Newton, Duman (bib35) 2004; 1 Jurata, Bukhman, Charles, Capriglione, Bullard, Lemire (bib40) 2004; 138 Weis, Llenos, Dulay, Elashoff, Martinez-Murillo, Miller (bib49) 2007; 165 Benjamini, Hochberg (bib10) 1995; 57 Owen MJ, Craddock N, Jablensky A (2007): The Genetic Deconstruction of Psychosis. 33:905-911. Arion, Unger, Lewis, Levitt, Mirnics (bib50) 2007; 62 Balcar, Nanitsos (bib30) 2006; 31 Britsch (bib42) 2007; 190 Vawter, Evans, Choudary, Tomita, Meador-Woodruff, Molnar (bib11) 2004; 29 Lee, Duman, Marek (bib36) 2006; 398 Stefansson, Sigurdsson, Steinthorsdottir, Bjornsdottir, Sigmundsson, Ghosh (bib44) 2002; 71 Su, Wiltshire, Batalov, Lapp, Ching, Block (bib20) 2004; 101 Mexal, Berger, Adams, Ross, Freedman, Leonard (bib19) 2006; 1106 McQuillin (10.1016/j.biopsych.2007.11.010_bib26) 2007; 17 Iwamoto (10.1016/j.biopsych.2007.11.010_bib7) 2005; 14 Altar (10.1016/j.biopsych.2007.11.010_bib15) 2005; 58 McCullumsmith (10.1016/j.biopsych.2007.11.010_bib28) 2005; 26 Jarskog (10.1016/j.biopsych.2007.11.010_bib24) 2006; 19 Duman (10.1016/j.biopsych.2007.11.010_bib37) 2004; 5 Li (10.1016/j.biopsych.2007.11.010_bib16) 2004; 13 Craddock (10.1016/j.biopsych.2007.11.010_bib3) 2006; 32 Jurata (10.1016/j.biopsych.2007.11.010_bib40) 2004; 138 Law (10.1016/j.biopsych.2007.11.010_bib43) 2003; 160 Craddock (10.1016/j.biopsych.2007.11.010_bib1) 2005; 42 10.1016/j.biopsych.2007.11.010_bib17 Duman (10.1016/j.biopsych.2007.11.010_bib34) 2006; 59 Stefansson (10.1016/j.biopsych.2007.11.010_bib44) 2002; 71 Britsch (10.1016/j.biopsych.2007.11.010_bib42) 2007; 190 10.1016/j.biopsych.2007.11.010_bib5 Santarelli (10.1016/j.biopsych.2007.11.010_bib22) 2003; 301 Iwamoto (10.1016/j.biopsych.2007.11.010_bib6) 2004; 9 Dranovsky (10.1016/j.biopsych.2007.11.010_bib21) 2006; 59 Craddock (10.1016/j.biopsych.2007.11.010_bib2) 2005; 186 Thompson (10.1016/j.biopsych.2007.11.010_bib41) 2007; 1139 Tomita (10.1016/j.biopsych.2007.11.010_bib8) 2004; 55 Arion (10.1016/j.biopsych.2007.11.010_bib50) 2007; 62 Konradi (10.1016/j.biopsych.2007.11.010_bib48) 2004; 61 Lee (10.1016/j.biopsych.2007.11.010_bib12) 2005; 6 Vawter (10.1016/j.biopsych.2007.11.010_bib11) 2004; 29 Atz (10.1016/j.biopsych.2007.11.010_bib18) 2007; 163 Vawter (10.1016/j.biopsych.2007.11.010_bib9) 2006; 11 Craddock (10.1016/j.biopsych.2007.11.010_bib4) 2007; 190 Choudary (10.1016/j.biopsych.2007.11.010_bib27) 2005; 102 Sun (10.1016/j.biopsych.2007.11.010_bib46) 2006; 31 Prabakaran (10.1016/j.biopsych.2007.11.010_bib47) 2004; 9 Harwood (10.1016/j.biopsych.2007.11.010_bib23) 2003; 3 Balcar (10.1016/j.biopsych.2007.11.010_bib30) 2006; 31 Chen (10.1016/j.biopsych.2007.11.010_bib25) 1999; 72 Benjamini (10.1016/j.biopsych.2007.11.010_bib10) 1995; 57 Mexal (10.1016/j.biopsych.2007.11.010_bib19) 2006; 1106 Harrison (10.1016/j.biopsych.2007.11.010_bib45) 2003; 361 Erraji-Benchekroun (10.1016/j.biopsych.2007.11.010_bib13) 2005; 57 Dias (10.1016/j.biopsych.2007.11.010_bib38) 2003; 45 Smith (10.1016/j.biopsych.2007.11.010_bib29) 2001; 158 Lauriat (10.1016/j.biopsych.2007.11.010_bib31) 2006; 137 Newton (10.1016/j.biopsych.2007.11.010_bib35) 2004; 1 Weis (10.1016/j.biopsych.2007.11.010_bib49) 2007; 165 Galfalvy (10.1016/j.biopsych.2007.11.010_bib14) 2003; 4 10.1016/j.biopsych.2007.11.010_bib32 D'Sa (10.1016/j.biopsych.2007.11.010_bib39) 2002; 4 Su (10.1016/j.biopsych.2007.11.010_bib20) 2004; 101 Deng (10.1016/j.biopsych.2007.11.010_bib33) 2004; 4 Lee (10.1016/j.biopsych.2007.11.010_bib36) 2006; 398 |
| References_xml | – volume: 165 start-page: 198 year: 2007 end-page: 209 ident: bib49 article-title: Quality control for microarray analysis of human brain samples: The impact of postmortem factors, RNA characteristics, and histopathology publication-title: J Neurosci Meth – volume: 32 start-page: 9 year: 2006 end-page: 16 ident: bib3 article-title: Genes for schizophrenia and bipolar disorder? publication-title: Schizophr Bull – volume: 102 start-page: 15653 year: 2005 end-page: 15658 ident: bib27 article-title: Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression publication-title: Proc Natl Acad Sci U S A – volume: 190 start-page: 1 year: 2007 end-page: 65 ident: bib42 article-title: The neuregulin-I/ErbB signaling system in development and disease publication-title: Cell Biol – volume: 29 start-page: 373 year: 2004 end-page: 384 ident: bib11 article-title: Gender-specific gene expression in post-mortem human brain: Localization to sex chromosomes publication-title: Neuropsychopharmacology – volume: 190 start-page: 361 year: 2007 ident: bib4 article-title: Symptom dimensions and the Kraepelinian dichotomy publication-title: Br J Psychiatry – volume: 4 start-page: 37 year: 2003 ident: bib14 article-title: Sex genes for genomic analysis in human brain: internal controls for comparison of probe level data extraction publication-title: BMC Bioinformatics – volume: 160 start-page: 1392 year: 2003 ident: bib43 article-title: Schizophrenia, IV: Neuregulin-1 in the human brain publication-title: Am J Psychiatry – volume: 138 start-page: 173 year: 2004 end-page: 188 ident: bib40 article-title: Comparison of microarray-based mRNA profiling technologies for identification of psychiatric disease and drug signatures publication-title: J Neurosci Meth – volume: 17 start-page: 605 year: 2007 end-page: 617 ident: bib26 article-title: A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder publication-title: Pharmacogenet Genomics – reference: Berger UV, Hediger MA (2006): Distribution of the glutamate transporters GLT-1 (SLC1A2) and GLAST (SLC1A3) in peripheral organs. 211:595–606. – volume: 1139 start-page: 95 year: 2007 end-page: 109 ident: bib41 article-title: Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain publication-title: Brain Res – volume: 158 start-page: 1393 year: 2001 end-page: 1399 ident: bib29 article-title: Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia publication-title: Am J Psychiatry – volume: 301 start-page: 805 year: 2003 end-page: 809 ident: bib22 article-title: Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants publication-title: Science – volume: 9 start-page: 964 year: 2004 end-page: 997 ident: bib47 article-title: Mitochondrial dysfunction in schizophrenia: Evidence for compromised brain metabolism and oxidative stress publication-title: Mol Psychiatry – volume: 61 start-page: 300 year: 2004 end-page: 308 ident: bib48 article-title: Molecular evidence for mitochondrial dysfunction in bipolar disorder publication-title: Arch Gen Psychiatry – volume: 19 start-page: 307 year: 2006 end-page: 312 ident: bib24 article-title: Apoptosis in schizophrenia: Pathophysiologic and therapeutic considerations publication-title: Curr Opin Psychiatry – volume: 398 start-page: 328 year: 2006 end-page: 332 ident: bib36 article-title: The mGlu2/3 receptor agonist LY354740 suppresses immobilization stress-induced increase in rat prefrontal cortical BDNF mRNA expression publication-title: Neurosci Lett – volume: 361 start-page: 417 year: 2003 end-page: 419 ident: bib45 article-title: Genes for schizophrenia? publication-title: Lancet – volume: 62 start-page: 711 year: 2007 end-page: 721 ident: bib50 article-title: Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia publication-title: Biol Psychiatry – volume: 42 start-page: 193 year: 2005 end-page: 204 ident: bib1 article-title: The genetics of schizophrenia and bipolar disorder: dissecting psychosis publication-title: J Med Genet – volume: 3 start-page: 472 year: 2003 end-page: 482 ident: bib23 article-title: Neurodevelopment and mood stabilizers publication-title: Current molecular medicine – volume: 57 start-page: 289 year: 1995 end-page: 300 ident: bib10 article-title: Controlling the false discovery rate—a practical and powerful approach to multiple testing publication-title: J Royal Stat Soc B Methodol – volume: 163 start-page: 295 year: 2007 end-page: 309 ident: bib18 article-title: Methodological considerations for gene expression profiling of human brain publication-title: J Neurosci Meth – volume: 59 start-page: 1116 year: 2006 end-page: 1127 ident: bib34 article-title: A neurotrophic model for stress-related mood disorders publication-title: Biol Psychiatry – volume: 58 start-page: 85 year: 2005 end-page: 96 ident: bib15 article-title: Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts publication-title: Biol Psychiatry – volume: 59 start-page: 1136 year: 2006 end-page: 1143 ident: bib21 article-title: Hippocampal neurogenesis: Regulation by stress and antidepressants publication-title: Biol Psychiatry – volume: 4 start-page: 21 year: 2004 ident: bib33 article-title: Association study of polymorphisms in the excitatory amino acid transporter 2 gene (SLC1A2) with schizophrenia publication-title: BMC Psychiatry – volume: 71 start-page: 877 year: 2002 end-page: 892 ident: bib44 article-title: Neuregulin 1 and susceptibility to schizophrenia publication-title: Am J Hum Genet – volume: 45 start-page: 553 year: 2003 end-page: 563 ident: bib38 article-title: Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain publication-title: Neuropharmacology – volume: 13 start-page: 609 year: 2004 end-page: 616 ident: bib16 article-title: Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions publication-title: Hum Mol Genet – volume: 57 start-page: 549 year: 2005 end-page: 558 ident: bib13 article-title: Molecular aging in human prefrontal cortex is selective and continuous throughout adult life publication-title: Biol Psychiatry – reference: Li JZ, Meng F, Tsavaler L, Evans SJ, Choudary PV, Tomita H, et al. (2007): Sample matching by inferred agonal stress in gene expression analyses of the brain. 8:336. – volume: 26 start-page: 368 year: 2005 end-page: 375 ident: bib28 article-title: Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder publication-title: Neuropsychopharmacology – volume: 5 start-page: 11 year: 2004 end-page: 25 ident: bib37 article-title: Role of neurotrophic factors in the etiology and treatment of mood disorders publication-title: Neuromol Med – volume: 4 start-page: 183 year: 2002 end-page: 194 ident: bib39 article-title: Antidepressants and neuroplasticity publication-title: Bipolar Disord – volume: 1106 start-page: 1 year: 2006 end-page: 11 ident: bib19 article-title: Brain pH has a significant impact on human postmortem hippocampal gene expression profiles publication-title: Brain Res – volume: 11 start-page: 663 year: 2006 end-page: 679 ident: bib9 article-title: Mitochondrial-related gene expression changes are sensitive to agonal-pH state: Implications for brain disorders publication-title: Mol Psychiatry – volume: 101 start-page: 6062 year: 2004 end-page: 6067 ident: bib20 article-title: A gene atlas of the mouse and human protein-encoding transcriptomes publication-title: Proc Natl Acad Sci U S A – volume: 186 start-page: 364 year: 2005 end-page: 366 ident: bib2 article-title: The beginning of the end for the Kraepelinian dichotomy publication-title: Br J Psychiatry – volume: 1 start-page: 261 year: 2004 end-page: 267 ident: bib35 article-title: Regulation of neurogenesis and angiogenesis in depression publication-title: Curr Neurovasc Res – volume: 31 start-page: 189 year: 2006 end-page: 196 ident: bib46 article-title: Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder publication-title: J Psychiatry Neurosci – volume: 72 start-page: 879 year: 1999 end-page: 882 ident: bib25 article-title: The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS publication-title: J Neurochem – volume: 14 start-page: 241 year: 2005 end-page: 253 ident: bib7 article-title: Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis publication-title: Hum Mol Genet – reference: Owen MJ, Craddock N, Jablensky A (2007): The Genetic Deconstruction of Psychosis. 33:905-911. – volume: 6 start-page: 269 year: 2005 ident: bib12 article-title: ErmineJ: Tool for functional analysis of gene expression data sets publication-title: BMC Bioinformatics – volume: 55 start-page: 346 year: 2004 end-page: 352 ident: bib8 article-title: Effect of agonal and postmortem factors on gene expression profile: Quality control in microarray analyses of postmortem human brain publication-title: Biol Psychiatry – volume: 9 start-page: 406 year: 2004 end-page: 416 ident: bib6 article-title: Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders publication-title: Mol Psychiatry – volume: 31 start-page: 685 year: 2006 end-page: 686 ident: bib30 article-title: Autoradiography of (3H)aspartate and glutamate transport in schizophrenia publication-title: Neuropsychopharmacology – volume: 137 start-page: 843 year: 2006 end-page: 851 ident: bib31 article-title: Quantitative analysis of glutamate transporter mRNA expression in prefrontal and primary visual cortex in normal and schizophrenic brain publication-title: Neuroscience – volume: 361 start-page: 417 year: 2003 ident: 10.1016/j.biopsych.2007.11.010_bib45 article-title: Genes for schizophrenia? publication-title: Lancet doi: 10.1016/S0140-6736(03)12379-3 – volume: 62 start-page: 711 year: 2007 ident: 10.1016/j.biopsych.2007.11.010_bib50 article-title: Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2006.12.021 – volume: 32 start-page: 9 year: 2006 ident: 10.1016/j.biopsych.2007.11.010_bib3 article-title: Genes for schizophrenia and bipolar disorder? publication-title: Schizophr Bull doi: 10.1093/schbul/sbj033 – volume: 398 start-page: 328 year: 2006 ident: 10.1016/j.biopsych.2007.11.010_bib36 article-title: The mGlu2/3 receptor agonist LY354740 suppresses immobilization stress-induced increase in rat prefrontal cortical BDNF mRNA expression publication-title: Neurosci Lett doi: 10.1016/j.neulet.2006.01.021 – volume: 13 start-page: 609 year: 2004 ident: 10.1016/j.biopsych.2007.11.010_bib16 article-title: Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions publication-title: Hum Mol Genet doi: 10.1093/hmg/ddh065 – volume: 4 start-page: 21 year: 2004 ident: 10.1016/j.biopsych.2007.11.010_bib33 article-title: Association study of polymorphisms in the excitatory amino acid transporter 2 gene (SLC1A2) with schizophrenia publication-title: BMC Psychiatry doi: 10.1186/1471-244X-4-21 – volume: 58 start-page: 85 year: 2005 ident: 10.1016/j.biopsych.2007.11.010_bib15 article-title: Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2005.03.031 – volume: 59 start-page: 1116 year: 2006 ident: 10.1016/j.biopsych.2007.11.010_bib34 article-title: A neurotrophic model for stress-related mood disorders publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2006.02.013 – volume: 57 start-page: 549 year: 2005 ident: 10.1016/j.biopsych.2007.11.010_bib13 article-title: Molecular aging in human prefrontal cortex is selective and continuous throughout adult life publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2004.10.034 – volume: 102 start-page: 15653 year: 2005 ident: 10.1016/j.biopsych.2007.11.010_bib27 article-title: Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0507901102 – volume: 55 start-page: 346 year: 2004 ident: 10.1016/j.biopsych.2007.11.010_bib8 article-title: Effect of agonal and postmortem factors on gene expression profile: Quality control in microarray analyses of postmortem human brain publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2003.10.013 – volume: 1139 start-page: 95 year: 2007 ident: 10.1016/j.biopsych.2007.11.010_bib41 article-title: Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain publication-title: Brain Res doi: 10.1016/j.brainres.2006.11.047 – volume: 19 start-page: 307 year: 2006 ident: 10.1016/j.biopsych.2007.11.010_bib24 article-title: Apoptosis in schizophrenia: Pathophysiologic and therapeutic considerations publication-title: Curr Opin Psychiatry doi: 10.1097/01.yco.0000218603.25346.8f – volume: 71 start-page: 877 year: 2002 ident: 10.1016/j.biopsych.2007.11.010_bib44 article-title: Neuregulin 1 and susceptibility to schizophrenia publication-title: Am J Hum Genet doi: 10.1086/342734 – ident: 10.1016/j.biopsych.2007.11.010_bib17 – volume: 1 start-page: 261 year: 2004 ident: 10.1016/j.biopsych.2007.11.010_bib35 article-title: Regulation of neurogenesis and angiogenesis in depression publication-title: Curr Neurovasc Res doi: 10.2174/1567202043362388 – volume: 137 start-page: 843 year: 2006 ident: 10.1016/j.biopsych.2007.11.010_bib31 article-title: Quantitative analysis of glutamate transporter mRNA expression in prefrontal and primary visual cortex in normal and schizophrenic brain publication-title: Neuroscience doi: 10.1016/j.neuroscience.2005.10.003 – volume: 138 start-page: 173 year: 2004 ident: 10.1016/j.biopsych.2007.11.010_bib40 article-title: Comparison of microarray-based mRNA profiling technologies for identification of psychiatric disease and drug signatures publication-title: J Neurosci Meth doi: 10.1016/j.jneumeth.2004.04.002 – volume: 5 start-page: 11 year: 2004 ident: 10.1016/j.biopsych.2007.11.010_bib37 article-title: Role of neurotrophic factors in the etiology and treatment of mood disorders publication-title: Neuromol Med doi: 10.1385/NMM:5:1:011 – volume: 160 start-page: 1392 year: 2003 ident: 10.1016/j.biopsych.2007.11.010_bib43 article-title: Schizophrenia, IV: Neuregulin-1 in the human brain publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.160.8.1392 – volume: 9 start-page: 964 year: 2004 ident: 10.1016/j.biopsych.2007.11.010_bib47 article-title: Mitochondrial dysfunction in schizophrenia: Evidence for compromised brain metabolism and oxidative stress publication-title: Mol Psychiatry doi: 10.1038/sj.mp.4001532 – volume: 301 start-page: 805 year: 2003 ident: 10.1016/j.biopsych.2007.11.010_bib22 article-title: Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants publication-title: Science doi: 10.1126/science.1083328 – volume: 165 start-page: 198 year: 2007 ident: 10.1016/j.biopsych.2007.11.010_bib49 article-title: Quality control for microarray analysis of human brain samples: The impact of postmortem factors, RNA characteristics, and histopathology publication-title: J Neurosci Meth doi: 10.1016/j.jneumeth.2007.06.001 – volume: 17 start-page: 605 year: 2007 ident: 10.1016/j.biopsych.2007.11.010_bib26 article-title: A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder publication-title: Pharmacogenet Genomics doi: 10.1097/FPC.0b013e328011b5b2 – volume: 101 start-page: 6062 year: 2004 ident: 10.1016/j.biopsych.2007.11.010_bib20 article-title: A gene atlas of the mouse and human protein-encoding transcriptomes publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0400782101 – volume: 29 start-page: 373 year: 2004 ident: 10.1016/j.biopsych.2007.11.010_bib11 article-title: Gender-specific gene expression in post-mortem human brain: Localization to sex chromosomes publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300337 – volume: 6 start-page: 269 year: 2005 ident: 10.1016/j.biopsych.2007.11.010_bib12 article-title: ErmineJ: Tool for functional analysis of gene expression data sets publication-title: BMC Bioinformatics doi: 10.1186/1471-2105-6-269 – volume: 190 start-page: 361 year: 2007 ident: 10.1016/j.biopsych.2007.11.010_bib4 article-title: Symptom dimensions and the Kraepelinian dichotomy publication-title: Br J Psychiatry doi: 10.1192/bjp.190.4.361 – volume: 31 start-page: 685 year: 2006 ident: 10.1016/j.biopsych.2007.11.010_bib30 article-title: Autoradiography of (3H)aspartate and glutamate transport in schizophrenia publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300976 – volume: 163 start-page: 295 year: 2007 ident: 10.1016/j.biopsych.2007.11.010_bib18 article-title: Methodological considerations for gene expression profiling of human brain publication-title: J Neurosci Meth doi: 10.1016/j.jneumeth.2007.03.022 – volume: 158 start-page: 1393 year: 2001 ident: 10.1016/j.biopsych.2007.11.010_bib29 article-title: Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.158.9.1393 – volume: 9 start-page: 406 year: 2004 ident: 10.1016/j.biopsych.2007.11.010_bib6 article-title: Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders publication-title: Mol Psychiatry doi: 10.1038/sj.mp.4001437 – ident: 10.1016/j.biopsych.2007.11.010_bib32 – volume: 14 start-page: 241 year: 2005 ident: 10.1016/j.biopsych.2007.11.010_bib7 article-title: Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis publication-title: Hum Mol Genet doi: 10.1093/hmg/ddi022 – ident: 10.1016/j.biopsych.2007.11.010_bib5 doi: 10.1093/schbul/sbm053 – volume: 72 start-page: 879 year: 1999 ident: 10.1016/j.biopsych.2007.11.010_bib25 article-title: The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS publication-title: J Neurochem doi: 10.1046/j.1471-4159.1999.720879.x – volume: 26 start-page: 368 year: 2005 ident: 10.1016/j.biopsych.2007.11.010_bib28 article-title: Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(01)00370-0 – volume: 59 start-page: 1136 year: 2006 ident: 10.1016/j.biopsych.2007.11.010_bib21 article-title: Hippocampal neurogenesis: Regulation by stress and antidepressants publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2006.03.082 – volume: 4 start-page: 183 year: 2002 ident: 10.1016/j.biopsych.2007.11.010_bib39 article-title: Antidepressants and neuroplasticity publication-title: Bipolar Disord doi: 10.1034/j.1399-5618.2002.01203.x – volume: 4 start-page: 37 year: 2003 ident: 10.1016/j.biopsych.2007.11.010_bib14 article-title: Sex genes for genomic analysis in human brain: internal controls for comparison of probe level data extraction publication-title: BMC Bioinformatics doi: 10.1186/1471-2105-4-37 – volume: 190 start-page: 1 year: 2007 ident: 10.1016/j.biopsych.2007.11.010_bib42 article-title: The neuregulin-I/ErbB signaling system in development and disease publication-title: Cell Biol – volume: 31 start-page: 189 year: 2006 ident: 10.1016/j.biopsych.2007.11.010_bib46 article-title: Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder publication-title: J Psychiatry Neurosci – volume: 42 start-page: 193 year: 2005 ident: 10.1016/j.biopsych.2007.11.010_bib1 article-title: The genetics of schizophrenia and bipolar disorder: dissecting psychosis publication-title: J Med Genet doi: 10.1136/jmg.2005.030718 – volume: 3 start-page: 472 year: 2003 ident: 10.1016/j.biopsych.2007.11.010_bib23 article-title: Neurodevelopment and mood stabilizers publication-title: Current molecular medicine doi: 10.2174/1566524033479672 – volume: 11 start-page: 663 year: 2006 ident: 10.1016/j.biopsych.2007.11.010_bib9 article-title: Mitochondrial-related gene expression changes are sensitive to agonal-pH state: Implications for brain disorders publication-title: Mol Psychiatry doi: 10.1038/sj.mp.4001830 – volume: 186 start-page: 364 year: 2005 ident: 10.1016/j.biopsych.2007.11.010_bib2 article-title: The beginning of the end for the Kraepelinian dichotomy publication-title: Br J Psychiatry doi: 10.1192/bjp.186.5.364 – volume: 45 start-page: 553 year: 2003 ident: 10.1016/j.biopsych.2007.11.010_bib38 article-title: Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain publication-title: Neuropharmacology doi: 10.1016/S0028-3908(03)00198-9 – volume: 57 start-page: 289 year: 1995 ident: 10.1016/j.biopsych.2007.11.010_bib10 article-title: Controlling the false discovery rate—a practical and powerful approach to multiple testing publication-title: J Royal Stat Soc B Methodol doi: 10.1111/j.2517-6161.1995.tb02031.x – volume: 1106 start-page: 1 year: 2006 ident: 10.1016/j.biopsych.2007.11.010_bib19 article-title: Brain pH has a significant impact on human postmortem hippocampal gene expression profiles publication-title: Brain Res doi: 10.1016/j.brainres.2006.05.043 – volume: 61 start-page: 300 year: 2004 ident: 10.1016/j.biopsych.2007.11.010_bib48 article-title: Molecular evidence for mitochondrial dysfunction in bipolar disorder publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.61.3.300 |
| SSID | ssj0007221 |
| Score | 2.3341622 |
| Snippet | Schizophrenia and bipolar disorder together affect approximately 2.5% of the world population, and their etiologies are thought to involve multiple genetic... BackgroundSchizophrenia and bipolar disorder together affect approximately 2.5% of the world population, and their etiologies are thought to involve multiple... |
| SourceID | pubmedcentral proquest pubmed pascalfrancis crossref elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 89 |
| SubjectTerms | Adult Adult and adolescent clinical studies AGXT2L1 antipsychotic medication apoptosis Biological and medical sciences bipolar disorder Bipolar Disorder - genetics Bipolar Disorder - physiopathology Bipolar disorders BUB1B dorsolateral prefrontal cortex EMX2 ERBB2 Excitatory Amino Acid Transporter 2 Female FGF2 FTH1 Gene Expression Profiling Gene Expression Regulation - genetics Genes, Tumor Suppressor Genetic Variation - genetics Glutamate Plasma Membrane Transport Proteins - genetics Humans IL2RA LGALS3 MAFG Male Medical sciences microarray Middle Aged Mood disorders neurogenesis Neuropharmacology NFATC1 Nuclear Proteins - genetics Oligonucleotide Array Sequence Analysis Pharmacology. Drug treatments Prefrontal Cortex - physiopathology Psychiatric/Mental Health Psycholeptics: tranquillizer, neuroleptic Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychopharmacology Psychoses PVR quantitative PCR Reference Values RERG Reverse Transcriptase Polymerase Chain Reaction Schizophrenia Schizophrenia - genetics Schizophrenia - physiopathology SLC1A2 SMCY SMO Social Environment SOX9 Transaminases - genetics Transcription, Genetic - genetics TU3A TXNIP |
| Title | Shared Gene Expression Alterations in Schizophrenia and Bipolar Disorder |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0006322307011043 https://www.clinicalkey.es/playcontent/1-s2.0-S0006322307011043 https://dx.doi.org/10.1016/j.biopsych.2007.11.010 https://www.ncbi.nlm.nih.gov/pubmed/18191109 https://www.proquest.com/docview/69230945 https://pubmed.ncbi.nlm.nih.gov/PMC3098561 |
| Volume | 64 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB71IaBShWB5pcDiA9d0EyeOk-N21WoB0QtU6s1yHEdNVWVXZCvBhd_OzMYOu1AJBNckk2jsL_OQZ74BeBtVFVG08NBYbsJURCbMa6nDBH11XqacV321xXk2v0jfX4rLHZj5Xhgqq3S2v7fpa2vtrkzcak6WTUM9vuheORUykw9Lk13Y50mRIbT3p-8-zM8Hgyw5d4PzspAENhqFr4_LZrGuK-7ZDInQk5pp7_ZRh0vd4crV_ciLu2LSX0srN3zV2SN46IJMNu31eAw7th3BvX7s5LcRPJj5KW8juP_RHa4_gTmRN9uKERM1O_3qKmRbNr1ZMy8TPlnTsk-bZXpMtxU7aZaUIDPP5PkULs5OP8_moRu0EBrcklUoSsmF1pqXhagyWwiR1HmWxlqYKqorK4XJuTaC25Liu1ImsuCRrFDNWhR5nTyDvXbR2hfAMmPTLNGWiOFTzObK2GhrJebB-EpepwEIv7TKOBZyGoZxo3y52bXyW0IjMiWmKAq3JIDJILfseTj-KCH9zinfZYp2UaGr-DdJ27nfu1Ox6riK1G8QDKAYJLdQ_FdfHW_Ba1CTqJXRZcUBvPF4UwgSOtjRrV3cdirDKB3TdBHA8x59P5eI8vE4KlClLVwODxC7-Padtrlas4zjG3NEx9F_qPQSDvryGhnG4hXsrb7c2tcYw63KMewef4_H7k_9AaUVRy8 |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nb9QwEB2VIigSQrB8hULrA9d0EyeOk2NZtVqg7YVW6s1yHEekqrIrspXgwm9nJna2u7RSK7gmcaKxnz0zyps3AB-jqiKJFh4ay02YisiEeS11mKCvzsuU88qxLU6y6Vn65Vycb8BkqIUhWqU_-92Z3p_W_srYz-Z43jRU44vulRORmXxYmjyAhyluX9qde7-veR6Sc982Lwvp8ZUy4Yu9spn1rGKnZUhynlRKe7uHejrXHc5b7Rpe3BaR_k2sXPFUh8_hmQ8x2b6z4gVs2HYEj1zTyV8j2JoMPd5G8PjY_1p_CVOSbrYVIx1qdvDT82Nbtn_Z6y4TOlnTsm-rJD2m24p9auaUHrNBx_MVnB0enE6moW-zEBpckEUoSsmF1pqXhagyWwiR1HmWxlqYKqorK4XJuTaC25Kiu1ImsuCRrNDMWhR5nbyGzXbW2rfAMmPTLNGWZOFTzOXK2GhrJWbB-EpepwGIYWqV8Rrk1ArjUg1ksws1LAk1yJSYoChckgDGy3Fzp8Jx5wg5rJwaakzxVFToKP5tpO385u5UrDquInUDgAEUy5FrGL7XV3fW4LU0k4SV0WHFAewOeFMIEvqto1s7u-pUhjE6JukigDcOfddTRNl4HBVo0houlw-Qtvj6nbb53muM4xtzRMe7_zBpF7amp8dH6ujzyddteOKINjKMxXvYXPy4sh8wmluUO_1u_QNdUUfz |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Shared+gene+expression+alterations+in+schizophrenia+and+bipolar+disorder&rft.jtitle=Biological+psychiatry+%281969%29&rft.au=Shao%2C+Ling&rft.au=Vawter%2C+Marquis+P&rft.date=2008-07-15&rft.eissn=1873-2402&rft.volume=64&rft.issue=2&rft.spage=89&rft_id=info:doi/10.1016%2Fj.biopsych.2007.11.010&rft_id=info%3Apmid%2F18191109&rft.externalDocID=18191109 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00063223%2FS0006322308X00137%2Fcov150h.gif |